Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Testing and health monitoring news

Show

From To
CROI 2019: Interventions raise men’s HIV testing rates

A financial incentive as small as a $3 voucher for food dramatically increases HIV testing in areas with high HIV infection rates but low rates of testing, researchers said here. In places where HIV testing and linkage to care among men remain low while new infections among women and deaths from HIV among men remain high, scaling up the use of such small incentives may be an effective tool in increasing the number of people who know their HIV status, Hae-Young Kim of the Africa Health Research Institute said.

Published
14 March 2019
From
Science Speaks
Detectable HIV Despite Treatment? Clonal Expansion Could Be The Culprit

In a study of people with a low but detectable viral load despite adherence to treatment, infected cells were apparently cloning themselves.

Published
14 March 2019
From
Poz
Self-testing helps the partners of people with HIV to test, but not to link to care

Asking people living with HIV in Malawi to pass on HIV self-testing kits to their sexual partners was an effective way to encourage partners to take a

Published
12 March 2019
By
Roger Pebody
Are CD4 counts still useful in the 'treat all' era?

CD4 cell testing before starting treatment is still essential even in the era of 'treat all' guidelines, two studies from southern Africa presented at the Conference on

Published
08 March 2019
By
Keith Alcorn
How many people who have used PrEP get HIV the same year? New York study finds out

One question often asked about pre-exposure prophylaxis (PrEP) use is how frequently people start PrEP while unknowingly having HIV, often because they have acquired it so recently

Published
07 March 2019
By
Gus Cairns
The length of time Americans with HIV remain infectious is falling, but slowly

In 2016, more than half of people with HIV in the United States took more than three years to be diagnosed, and more than five months after

Published
07 March 2019
By
Roger Pebody
HIV infections lowered by 30% in universal testing and treatment study

Communities in southern Africa which received a door-to-door HIV testing intervention and support for linkage to care had substantially lower HIV incidence, the Conference on Retroviruses and

Published
06 March 2019
By
Roger Pebody
Point-of-care viral load testing improves treatment outcomes and retention in care

Same-day provision of results from a point-of-care viral load test – rather than waiting weeks for laboratory results to be collected – resulted in a 14% improvement

Published
05 March 2019
By
Roger Pebody
HIV prevention study finds universal 'test and treat' approach can reduce new infections

New HIV infections declined by 30 percent in southern African communities where health workers conducted house-to-house voluntary HIV testing, referred people who tested positive to begin HIV treatment according to local guidelines, and offered other proven HIV prevention measures to those who tested negative. Local guidelines evolved during the study from offering HIV treatment based on immune health to offering immediate treatment for all.

Published
05 March 2019
From
NIH/National Institute of Allergy and Infectious Diseases
'Test and Treat' reduces new HIV infections by a third in African communities

New HIV infections in southern Africa could be reduced substantially by offering entire communities voluntary HIV testing, and immediately referring those who test positive for HIV treatment in line with local guidelines, according to new research presented at the Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle, USA today.

Published
05 March 2019
From
Imperial College London
← First12345...125Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.